(Q39421012)

11 September 2017

title

Observation option toolkit for acute otitis media (English)

1 reference

11 September 2017

1 reference

Rosenfeld RM

1

1 reference

11 September 2017

publication date

1 April 2001

1 reference

International Journal of Pediatric Otorhinolaryngology

11 September 2017

published in

1 reference

11 September 2017

volume

58

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

1-8

1 reference

Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Evidence based medicine: what it is and what it isn't

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Otitis media. Clinical observations, microbiology, and evaluation of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Therapy of acute otitis media: myringotomy, antibiotics, or neither? A double-blind study in children

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Penicillin in acute otitis media: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Co-amoxiclav in recurrent acute otitis media: placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Acute red ear in children: controlled trial of non-antibiotic treatment in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Treatment failure in acute otitis media. A clinical study of children during their first three years of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Host factors and early therapeutic response in acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Five vs. ten days of antibiotic therapy for acute otitis media in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900421-9

7 January 2021

10.1016/S0165-5876(01)00421-9

Identifiers

DOI

1 reference

release_4sjwafybanb7pmujorgirtvehq

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4sjwafybanb7pmujorgirtvehq

24 November 2022

mapped directly with Wikidata item

1 reference